<DOC>
	<DOCNO>NCT02971462</DOCNO>
	<brief_summary>The purpose study investigate whether remote ischemic conditioning ( RIC ) would reduce stroke risk patient symptomatic vertebrobasilar lesion atherosclerosis , would observe haemodynamics plasma biomarkers change .</brief_summary>
	<brief_title>Remote Ischemic Conditioning Reducing Stroke Risk Symptomatic Vertebrobasilar Lesion Atherosclerosis</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Vertebrobasilar Insufficiency</mesh_term>
	<criteria>Male female age 18 80 year old . Patients ischemic stroke TIA within 30 day mRS score≤4 prior randomization . The entry event attribute symptomatic atherosclerotic lesion（stenosis great equal 50 % occlusion）in vertebrobasilar artery document magnetic resonance angiography ( MRA ) compute tomographic angiography ( CTA ) . Informed consent obtain . 1 . Thrombolytic therapy within 24 hour prior enrollment . 2 . Progressive neurological sign within 24 hour prior enrollment . 3 . Cerebral venous thrombosis/stenosis . 4. vertebrobasilar lesion due arterial dissection , Moya Moya disease ; know vasculitic disease ; herpes zoster , varicella zoster viral vasculopathy ; neurosyphilis ; infection ; artery stenosis associate cerebrospinal fluid ( CSF ) pleocytosis ; radiation induce vasculopathy ; fibromuscular dysplasia ; sickle cell disease ; neurofibromatosis ; benign angiopathy central nervous system ; postpartum angiopathy ; suspect vasospastic process , suspect recanalized embolus . 5 . Any following unequivocal cardiac source embolism : rheumatic mitral aortic stenosis , prosthetic heart valve , atrial fibrillation , atrial flutter , sick sinus syndrome , leave atrial myxoma , patent foramen ovale , leave ventricular mural thrombus valvular vegetation , congestive heart failure , bacterial endocarditis , cardiovascular condition interfere participation . 6 . Uncontrolled severe hypertension [ sit systolic blood pressure ( SBP ) &gt; 180 mmHg and/or sit diastolic blood pressure ( DBP ) &gt; 110 mmHg medication ] . 7 . Patients serious complication abnormal laboratory parameter : aspartate transaminase ( AST ) and/or alanine transaminase ( ALT ) &gt; 3×upper limit normal range ; creatinine clearance &lt; 0.6 ml/s and/or serum creatinine &gt; 265 μmol/l ( &gt; 3.0 mg/dl ) ; platelet &lt; 100×109/L . 8 . Any intracranial hemorrhage ( parenchymal , subarachnoid , subdural , epidural ) within 90 day prior enrollment . 9 . Intracranial neoplasm , cerebral aneurysm arteriovenous malformation . 10 . Known retinal hemorrhage visceral bleeding within 30 day prior enrollment . 11 . Severe hemostatic disorder severe coagulation dysfunction . 12 . Subclavian arterial stenosis≥50 % subclavian steal syndrome . 13 . Previous treatment target lesion stent , angioplasty , mechanical device , plan perform one procedure within 12 month enrollment . 14 . Major surgery ( include open femoral , aortic , carotid surgery , cardiac ) within previous 30 day schedule 6 month enrollment . 15 . Contraindication remote ischemic conditioning : severe soft tissue injury , fracture , peripheral vascular disease upper limb . 16 . Pregnant breastfeed woman . 17 . Unwilling follow poor compliance treatment . 18 . Patients enrol enrolled clinical trial within 3 month prior clinical trial . 19 . Patients unsuitable enrollment clinical trial accord investigator decision making .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>stroke</keyword>
	<keyword>Vertebrobasilar atherosclerosis</keyword>
	<keyword>remote ischemic conditioning</keyword>
</DOC>